Bristol Myers BMY announced that the European Commission (EC) has approved a label ... Use of the European Medicines Agency had earlier given a positive opinion, recommending Abecma’s approval ...
of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ ®, Valneva’s single-dose vaccine for the prevention of disease caused ...
The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.